Delivery Order SPE2DB24D2003-SPE2DB24FXEF7
Award Date
5/6/24
Potential Completion Date
5/7/24
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $3,991.12 and an ultimate completion date of October 28, 2024. The contract was awarded to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. AmerisourceBergen Drug Corp...
This federal contract award is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $4,734.00. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is January 30, 2024. Amerisourcebergen Drug Corp is a major...
This federal contract award is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,606.76 and an ultimate completion date of December 14, 2023. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML to the agency's facilities. The contract was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has a ceiling value of $12,807.02 and a performance period ending on May 9, 2024. This contract is part of a larger Indefinite Delivery...
This federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $7,136.28. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 21, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award is for the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $24,225.11 firm fixed-price delivery order has an ultimate completion date of December 10, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for...
This federal contract award is for the delivery of the pharmaceutical product Mounjaro 2.5 mg/0.5 mL pen in 0.5 mL dosage. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $4,058.83 and a period of performance through April 26, 2024. This award is not set aside for any specific business classification. Amerisourcebergen Drug Corp is a major...
This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,453.84, is a firm-fixed price delivery order with an ultimate completion date of October 18, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces....
The federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $41,031.57 firm fixed-price delivery order contract has a completion date of December 9, 2024. This award is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract, valued at $3,704.54, is a delivery order with a firm fixed price and an ultimate completion date of July 22, 2024. The prime contractor for this award is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. As a large pharmaceutical distributor, Amerisourcebergen...